Choose a folder
DISCOVER presentation success at ADA 2017
Dr Mikhail Kosiborod of the DISCOVER Scientific Committee gave an excellent oral presentation on vascular complications in patients enrolled in DISCOVER on Monday 12 June at the 77th Scientific Sessions of the American Diabetes Association.
The oral presentation described a multivariate analysis of factors associated with an increased likelihood of having microvascular complications such as chronic kidney disease and retinopathy, and macrovascular complications including stroke and coronary artery disease. At enrolment into DISCOVER, the prevalence of microvascular and macrovascular complications in patients with type 2 diabetes starting second-line glucose-lowering treatment was 17.9% and 12.9%, respectively. The prevalence of complications varied greatly across regions, and the highest levels were found in Europe. The analysis also found that glycated haemoglobin (HbA1c) levels were positively associated with microvascular but not macrovascular complications. The high prevalence of vascular complications in these patients with a relatively short duration of diabetes highlights an opportunity for early risk-factor management, particularly in regions with a high prevalence of complications.
Thank you to all the investigators for continuing to play a vital part in collecting the data for DISCOVER. For further updates, please keep visiting the DISCOVER website.
Approval ID: Z4-5283 Date of preparation: 23 June 2017 Date of expiry: 23 June 2018